A Study of Lepodisiran (LY3819469) in Participants With Normal, Mild, Moderate, or Severe Liver Function

NCT06916078 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

33

Enrollment

INDUSTRY

Sponsor class

Conditions

Liver Dysfunction
Healthy

Interventions

DRUG: Lepodisiran

Sponsor

Eli Lilly and Company